Project Grant R01DK147813
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the Regents of the University of Michigan a $779,978 Project Grant on September 6, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This research initiative addresses critical health disparities in diabetes management by developing and testing adaptive intervention sequences designed to improve outcomes for individuals with...
- Federal Project Grant Award Summary Colorado State University's Sponsored Programs division received a $183,540 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 1, 2026, through March 31, 2031. The award supports development of a Just-In-Time Adaptive Intervention (JITAI) to promote physical activity in adolescents with Type 2 Diabetes. The...
- Federal Project Grant Award Summary Scripps Health received a $574,932 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective July 1, 2026 through June 30, 2031. The award funds the EDGE (Enhancing Dulce Digital with CGM-Driven Personalization, Peer Support, Gamification, and Engagement) intervention, a digital health platform designed to improve...
- Federal Project Grant Award Summary The University of Pennsylvania received a $661,994 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 20, 2025, with completion targeted for June 30, 2026. The award funds development and testing of a remote, home-based prehabilitation intervention for kidney transplant (KT) candidates designed to...
- Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases awarded a Project Grant of $784,276 to the University of Houston, effective July 1, 2026 through June 30, 2031, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research project, titled "Supporting Monitoring and Remote Tracking for Prediabetes (SMART Prediabetes)," develops and evaluates continuous glucose monitor (CGM) use in federally qualified...
- Summary of Federal Project Grant Award The University of Michigan received a $769,155 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), with an award date of September 12, 2025, and completion date of July 31, 2030. The grant funds the Michigan Diabetes Project, a research initiative designed to develop and evaluate a virtually administered,...
- Federal Grant Award Summary Emory University received an $818,481 Project Grant award (dated September 15, 2025) from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a prospective longitudinal cohort study examining the quality of everyday life experiences among home dialysis patients and their family caregivers. The five-year study (through July 31, 2030) will enroll...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases awarded a $5.67 million Project Grant to the University of California, San Diego on September 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The four-year award, with completion scheduled for September 14, 2029, funds basic biomedical research investigating renal metabolism changes in sepsis-associated acute kidney injury (AKI). The...
- Federal Project Grant Award Summary The University of Michigan's Regents (through its Office of Research and Sponsored Projects) received a $780,220 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective February 27, 2026, with a completion date of January 31, 2030. This research initiative develops and evaluates a scalable digital behavioral...
- Federal Grant Award Summary The University of California, Davis received a $151,448 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 15, 2026, with completion scheduled for January 31, 2031. This grant funds research to improve transitions from pediatric to adult care for adolescents and young adults (AYAs) with Type 1 Diabetes (T1D)...
STEPNET-ADAPT Project Grant Summary The University of California, San Diego received a $796,998 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective July 9, 2026, with a completion date of February 28, 2031. The award funds the STEPNET-ADAPT initiative, a sequential multiple assignment randomized trial (SMART) designed to develop and evaluate a personalized, adaptive mobile health intervention for increasing physical activity in hemodialysis patients. The intervention delivers wearable activity trackers, automated personalized text messaging incorporating behavioral strategies such as goal-setting and self-monitoring, and tiered behavioral support including online or in-person coaching for non-responsive participants. The 12-month study consists of a 6-month intervention phase followed by a 6-month observational period, with real-time adaptation mechanisms triggered when participants fail to meet step goals for four consecutive weeks. The primary deliverable is evidence regarding intervention efficacy, measured by changes in average weekly step count from baseline to six months. Secondary outcomes include quantitative assessments of intervention engagement, hospitalizations, cardiovascular events, all-cause mortality, and cost-effectiveness data. This research addresses a significant clinical gap by transitioning from standardized approaches to a dynamic, personalized framework for physical activity promotion in hemodialysis care, with particular focus on identifying non-responders and delivering tailored adaptive augmentation to improve health outcomes in this vulnerable population.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $797.0k | 7/10/26 |